Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.

Krause, Philip R; Gruber, Marion F

Krause, Philip R; Gruber, Marion F.

Krause PR; From the Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
Gruber MF; From the Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD.

N Engl J Med ; 383(19): e107, 2020 Nov 05.

Article in English | MEDLINE | ID: covidwho-872775

Subject(s)

COVID-19 Vaccines; COVID-19/prevention & control; Drug Approval; Pandemics/prevention & control; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; Clinical Trials as Topic/standards; Follow-Up Studies; Humans; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Approval / Pandemics / COVID-19 Vaccines / COVID-19 Type of study: Cohort study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: N Engl J Med Year: 2020 Document Type: Article Affiliation country: NEJMp2031373

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google